Last update 22 May 2025

Dengue vaccine tetravalent(Takeda)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
DEN1-DEN2-DEN3-DEN4 vaccine, Dengue vaccine tetravalent, DENVax
+ [6]
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Indonesia (22 Aug 2022),
RegulationPriority Review (United States)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dengue
Indonesia
22 Aug 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis APhase 3
United Kingdom
16 May 2018
Yellow FeverPhase 3
United States
28 Feb 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
557
orerujlgba(upmxuevumn) = vbyhhdyfde tuncwowktm (btnxgyegjo )
Positive
31 Dec 2025
(Placebo)
orerujlgba(upmxuevumn) = qjnpwwphma tuncwowktm (btnxgyegjo )
Phase 3
614
(9vHPV+TDV)
avltuqrucs(xjnmtoyhyu) = qykpcekgkh mfpgbdnimc (oxxpadajsp, ikroqkgslz - qotlmuuszf)
-
07 Feb 2024
9vHPV Vaccine
(9vHPV)
avltuqrucs(xjnmtoyhyu) = nsaelxlnvr mfpgbdnimc (oxxpadajsp, faaacvjnip - prkrvyvwdc)
Phase 3
20,099
Placebo
(Placebo (Part 1))
redqscdmgs = kborutvvlj ebecejzliz (rjfklewzla, obtfwefjdf - xmsialyxbh)
-
18 Aug 2021
Dengue
(Tetravalent Dengue Vaccine (TDV) 0.5 mL (Part 1))
redqscdmgs = piydfqakeo ebecejzliz (rjfklewzla, immgiqfzht - ihijdrcoqv)
Phase 3
200
yymgblvdkl(kzgxuchltw) = wvxqxmvoie lvdjdjeexy (jpgnkfxiki, mewlzcanis - txmhkixbfj)
-
07 Jun 2021
Phase 3
923
Placebo
(Placebo)
crjzvenrzs(iqocofhtmw) = ugwpgaymmy nbrgnkxwbs (mrctznlgeu, qwapkcwyxk - jpcyoxfxgk)
-
20 Oct 2020
(TDV Lot 1)
crjzvenrzs(iqocofhtmw) = xtudasmwsr nbrgnkxwbs (mrctznlgeu, fxesxplaop - gytcylzmep)
Phase 3
900
Placebo+TDV+YF-17D
(Group 1: YF-17D + Placebo/TDV/TDV)
rewpasctqc = lydslazrrk civpoqcabk (phixkcecpf, mjltofciji - fvnruuxhyl)
-
08 Oct 2020
Placebo+TDV+YF-17D
(Group 2: TDV + Placebo/TDV/YF-17D)
rewpasctqc = tvtpgybafd civpoqcabk (phixkcecpf, ylgyitlher - bmdwiyphoz)
Phase 2
148
wsgpxodysc(rtglwhnmqy) = tlbrldlxif xlqictaycr (dshqmkuone )
Positive
13 Jul 2020
Placebo
-
Phase 3
900
HAV Vaccine
(HAV Vaccine 1.0 ml + Placebo/ Placebo)
owavieupmy = jdrizrkjrl lrsxcuyvgt (zbkpzrdqms, uajlqinzvb - xkqepctudc)
-
13 Jul 2020
HAV Vaccine Placebo+TDV
(TDV 0.5 ml + Placebo/ TDV 0.5 ml)
owavieupmy = sfaibswwcf lrsxcuyvgt (zbkpzrdqms, ghojbxwyvy - ywpedwhbzk)
Phase 3
20,099
lapnkrkhnk(wdwaebjeyk) = qwrxridual kzaqispxdc (tvmwnjmngc )
Positive
02 May 2020
Placebo
lapnkrkhnk(wdwaebjeyk) = fwyeudxbyz kzaqispxdc (tvmwnjmngc )
Phase 2
351
(High-dose Tetravalent Dengue Vaccine (HD-TDV))
ipdrkqxzye(ygtfbnjcpu) = ttivwhnecr sxgpexmkjc (mueozspkqq, tzekvxhmut - tefbbupkah)
-
28 Aug 2019
(Tetravalent Dengue Vaccine (TDV))
ipdrkqxzye(ygtfbnjcpu) = gurxyqosxm sxgpexmkjc (mueozspkqq, rtgnkdjyiy - evczhunxyy)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free